Our reports help you make sense of the prescription drugs market.

In an effort to keep our clients in the know, WellDyneRx publishes a biannual drug pipeline report.

Each report contains:

  • Descriptions of newly approved drugs, including product highlights, place in therapy, and market impact.
  • Summaries of specialty, non-specialty, biosimilar, and generic drugs with anticipated FDA approval dates in the upcoming 12 months.
  • Additional FDA actions, including rejections and indications for specific drugs.

Explore the latest below.

In addition, WellDyneRx also publishes a yearly Drug Trend Report. This provides an in-depth look at U.S. prescription drug costs, examines how they’re being utilized, and explores any factors that could influence the future of the marketplace.

Biosimilar Drug Pipeline Report

This report summarizes biosimilar drugs with anticipated FDA approval dates within the next 12 months.

Brand Drug Pipeline Report

This report summarizes brand drugs with anticipated FDA approval dates within the next 12 months.

Generic Drug Pipeline Report

This report summarizes generic drugs with anticipated FDA approval dates within the next 12 months.

Specialty Drug Pipeline Report

This report summarizes specialty drugs with anticipated FDA approval dates within the next 12 months.

Drug Trend Report

Coming May 2018

Stay up to date on our Drug and Formulary Reports